NHRA – issues updated “Medicine Renewal Guideline” V 2.1 & “Medicine Variations Guideline” V 3.1
NHRA issues updated “Medicine Renewal Guideline” (Version 2.1) & “Medicine Variations Guideline”
Regulinked
- November 13, 2025
- Guideline
- No Comments
Category: Market Access
NHRA – updated “International Manufacturing Site Licensing Procedure”
NHRA issues updated “International Manufacturing Site Licensing Procedure” Guideline (Version 1.6)
- November 10, 2025
- Guideline
- No Comments
SFDA- “Verification & Abridged Pathways” Guideline updates
SFDA issues updated “Verification & Abridged Pathways” Guideline (Version 3.0 — Issued
- October 31, 2025
- Acceleration process
- No Comments
ReguLinked Consulting helps pharmaceutical, healthcare, and life sciences companies achieve seamless market access and regulatory compliance across Saudi Arabia and the GCC. Trusted expertise. Local insight. Real results.
Contact
- +971555473407
- BD@regulinked.com
- consultation@regulinked.com